SCHEMBL174460

SCHEMBL174460

N#Cc1c[nH]nc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4850505 0.98
SCHEMBL28063810 0.84 MAP2K1 (0.32)
1,2,4-Triazole SCHEMBL28120435 0.84 MAP2K1 (0.32)
SCHEMBL5756852 0.71
SCHEMBL16660378 0.71
SCHEMBL16297134 0.71
SCHEMBL29118313 0.71
SCHEMBL3358649 0.71
SCHEMBL21260141 0.71
SCHEMBL31421043 0.69 HRH2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12291639-B2 Electrically conducting poly(pyrazoles) THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2025-05-06 US claimed
US-12195474-B2 Preparation method of zaleplon XINXIANG MEDICAL COLLEGE (CN) 2025-01-14 US claimed
US-20240182714-A1 Electrically Conducting Poly(pyrazoles) THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2024-06-06 US claimed
CN-117903143-A Synthetic method of initiating explosive ICM-103 and intermediate thereof 中北大学 2024-04-19 CN claimed
CN-117903142-A Synthetic method of initiating explosive ICM-103 中北大学 2024-04-19 CN claimed
CN-117603211-A Pyrazolotriazine high-nitrogen energetic molecule and synthesis method thereof 中国工程物理研究院化工材料研究所 2024-02-27 CN claimed
CN-116675691-A Perylene-based nitrogen-containing organic derivative, modified resin, preparation method, composite material and application 西南科技大学 2023-09-01 CN claimed
US-11618821-B2 Electrically conducting poly(pyrazoles) THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2023-04-04 US claimed
US-20230054994-A1 Electrically Conducting Poly(pyrazoles) THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2023-02-23 US claimed
WO-2022174540-A1 PREPARATION METHOD FOR ZALEPLON 新乡医学院 2022-08-25 WO claimed
WO-2002100828-A2 PROCESS FOR THE PRODUCTION OF ZALEPLON BIOGAL GYOGYSZERGYAR RT (HU) 2002-12-19 WO claimed
EP-0776898-B1 Process improvement in the synthesis of N-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamide AMERICAN CYANAMID CO (US) 2002-11-06 EP claimed
EP-0743574-B1 Migration imaging members XEROX CORP (US) 2000-12-27 EP claimed
CN-1057525-C Process improvement in synthesis of N-[3-(3-cyanopyrazolo[1,5-alpha] pyrimidin-7-yl) phenyli-N-ethyl-acetamide AMERICAN CYANAMID CO (US) 2000-10-18 CN claimed
EP-0743573-B1 Method for obtaining image contrast migration imaging members XEROX CORP (US) 2000-09-06 EP claimed
EP-0673783-B1 Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds XEROX CORP (US) 2000-07-05 EP claimed
US-5714607-A IMPROVED YIELDS ARE OBTAINED AT DECREASED REACTION TIMES BY ADDING WATER TO ACETIC ACID DURING REACTION OF 3-DIMETHYLAMINO-1-(3-N-ETHYL-N-ACETYLAMINOPHENYL)-2-PROPEN-1-ONE WITH 3-AMINOPYRAZOLE-4-CARBONITRILE AMERICAN CYANAMID COMPANY (US) 1998-02-03 US claimed
CN-1163893-A Process improvement in synthesis of N-[3-(3-cyanopyrazolo[1,5-alpha] pyrimidin-7-yl) phenyli-N-ethyl-acetamide AMERICAN CYANAMID CO (US) 1997-11-05 CN claimed
EP-0776898-A1 Process improvement in the synthesis of N-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamide American Cyanamid Company (US) 1997-06-04 EP claimed
US-4267324-A BY REACTION OF FORMAMIDINE AND 3-AMINO-4-CYANOPYRAZOLE POLAROID CORPORATION (US) 1981-05-12 US claimed